# The Medicines for Human Use (Clinical Trials) Amendment Regulations 2006, Regulation 31: Amendment of Schedule 6 to the principal Regulations


In Schedule 6 to the principal Regulations (particulars that must accompany an application for a manufacturing authorisation)—
(a) for paragraph 2 substitute—
“2 A statement describing the types of investigational medicinal product in respect of which the authorisation is required, including their pharmaceutical forms.”; and
(b) after paragraph 3, insert the following paragraph—
“3A Where the application relates to the inactivation of viral or non-conventional agents, a statement of the manufacturing process to which the authorisation is to relate.”.

---
Source: https://www.legislation.gov.uk/uksi/2006/1928/regulation/31 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-amendment-regulations-2006/regulation-31
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.